Re mesoblast purchase of technology for gvd and crohns desease.Approval has already been granted for GVD in Canada and New Zealand for this technology so why would they grant it if it doesnt work?The phase 3 trials are mandatory yes and have to be completed.The technolgy works and only needs the regulatory process to be comleted to enable it to reach the market,end of story.There are alot of private companies carrying out stem cell transplants for humans and animals with good success rates.Mesoblasts pathway to market will see it dominate the sector for a long time as it will be the first company that has a product in the market place, with patents in place that has gone through the correct regulatory processes.
manipulation rife on asx say researchers, page-20
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.010(0.69%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.43 | $4.048M | 2.778M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 26808 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 16001 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |